2022 SHORTLIST

Best ADC Platform Technology

IntoCell
Catalent's SMARTag Technology
Tubulis GmbH
Ajinomoto Bio-Pharma Services
Synaffix

Most Promising Clinical Candidate

DS-1062a (Daiichi Sankyo / AstraZeneca)
Patritumab deruxtecan (Daiichi Sankyo)
Mirvetuximab soravtansine (ImmunoGen)
Trastuzumab duocarmazine (Byondis)
Camidanlumab tesirine
(ADC Therapeutics)

Best New Drug Developer

Exelixis
Tubulis GmbH
Adcendo
Iksuda Therapeutics
Adcentrx

Best CMO

WuXi Biologics
MilliporeSigma
Catalent Pharma Solutions
Ajinomoto Bio-Pharma Servies
BSP Pharmaceuticals

Best CRO

Charles River Laboratories
NJ Biopharmaceuticals
Covance
Abzena
Eurofins